The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study

Aurélien Amiot(Université Paris-Est Créteil), Fabiana Castiglione, Mariabeatrice Principi, Xavier Roblin(Centre Hospitalier Universitaire de Saint-Étienne), Stéphane Nancey, Johan Burisch(University of Copenhagen), Frédéric Heluwaert(Centre Hospitalier Annecy Genevois), Zia Mazhar, Gilles Macaigne(Institution de Lavigny), Denis Franchimont(McGill University Health Centre), Glen Doherty(University College Dublin), Sebastian Zeißig(University of Bern), Georgios Michalopoulos, Piotr Eder(Poznan University of Medical Sciences), Ailsa Hart(St Mark's Hospital), Laurent Beaugerie(Assistance Publique – Hôpitaux de Paris), Gareth Parkes, Jean-Christophe Valats, Jeffrey Butterworth, Jean‐François Rahier(CHU Dinant Godinne UCL Namur), Eugeni Domènech(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Guillaume Bouguen(Inserm), Mathurin Fuméry(Centre Hospitalier Universitaire Amiens-Picardie), Pierre Blanc, Richard Shenderey(AZ Delta), Konstantinos Κarmiris(The General Hospital of Heraklion "Venizeleio-Pananio"), Livia Biancone(University of Rome Tor Vergata), Jimmy K. Limdi(Pennine Acute Hospitals NHS Trust), Hersin Tsai, Filip Baert(AZ Delta), Xavier Hébuterne, Jean‐Marc Gornet(Hôpital Saint-Louis), Catherine Reenears(University of Copenhagen), Natalia Pedersen(Slagelse Hospital), Jean-Marie Reimund, Guillaume Pineton de Chambrun, Sohail Shariq, Mohsin Gangi, Stéphane Nahon(Groupe Hospitalier Intercommunal Le Raincy Montfermeil), A. S. Bell(University of Glasgow), Marie Dewitte
Journal of Crohn s and Colitis
June 29, 2022
Cited by 14


Related Papers